Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors.
about
Dissociation of minor groove binders from DNA: insights from metadynamics simulations.From multiply active natural product to candidate drug? Antibacterial (and other) minor groove binders for DNA.A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin.Mutagen Synergy: Hypermutability Generated by Specific Pairs of Base Analogs.
P2860
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase I dose-escalation study ...... ts with advanced solid tumors.
@ast
Phase I dose-escalation study ...... ts with advanced solid tumors.
@en
type
label
Phase I dose-escalation study ...... ts with advanced solid tumors.
@ast
Phase I dose-escalation study ...... ts with advanced solid tumors.
@en
prefLabel
Phase I dose-escalation study ...... ts with advanced solid tumors.
@ast
Phase I dose-escalation study ...... ts with advanced solid tumors.
@en
P2093
P1476
Phase I dose-escalation study ...... ts with advanced solid tumors.
@en
P2093
A Petroccione
F Caponigro
F Fiorentini
M G Jannuzzo
R MacArthur
P2888
P304
P356
10.1007/S00280-009-1175-6
P577
2009-11-22T00:00:00Z
P5875
P6179
1051984081